hepatocellular carcinoma program (Omega Therapeutics)

N/A

Report date: 2025/01/26 18:23:05

Base Information

Drug Namehepatocellular carcinoma program (Omega Therapeutics)
Drug Alias NameOmega Epigenomic Controller (Omega Therapeutics)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOmega Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesOmega Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A